Two Sigma Advisers’s Cytosorbents Corp CTSO Stock Holding History

Two Sigma Advisers’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-830	Closed	-$23K	–	2547
2022 Q3	$23K	Sell	830 -545	-40%	-$21.3K	﹤0.01%	2434
2022 Q2	$60K	Buy	1,375 +500	+57%	+$23K	﹤0.01%	2458
2022 Q1	$56K	Sell	875 -2,190	-71%	-$157K	﹤0.01%	2572
2021 Q4	$257K	Sell	3,065 -1,385	-31%	-$155K	﹤0.01%	2191
2021 Q3	$723K	Sell	4,450 -2,615	-37%	-$425K	﹤0.01%	1763
2021 Q2	$1.07M	Sell	7,065 -3,665	-34%	-$618K	﹤0.01%	1606
2021 Q1	$1.86M	Buy	10,730 +3,375	+46%	+$643K	0.01%	1298
2020 Q4	$1.17M	Sell	7,355 -2,395	-25%	-$401K	﹤0.01%	1490
2020 Q3	$1.56M	Buy	9,750 +2,855	+41%	+$515K	﹤0.01%	1289
2020 Q2	$1.36M	Buy	6,895 +1,370	+25%	+$252K	﹤0.01%	1422
2020 Q1	$854K	Sell	5,525 -1,360	-20%	-$137K	﹤0.01%	1570
2019 Q4	$530K	Buy	6,885 +1,555	+29%	+$136K	﹤0.01%	1859
2019 Q3	$536K	Sell	5,330 -730	-12%	-$84.9K	﹤0.01%	1690
2019 Q2	$801K	Sell	6,060 -510	-8%	-$70.1K	﹤0.01%	1622
2019 Q1	$995K	Sell	6,570 -400	-6%	-$62.3K	﹤0.01%	1530
2018 Q4	$1.13M	Sell	6,970 -1,445	-17%	-$287K	﹤0.01%	1430
2018 Q3	$2.17M	Sell	8,415 -2,293	-21%	-$575K	0.01%	1187
2018 Q2	$2.44M	Buy	+10,708	New	+$2.03M	0.01%	1208

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Two Sigma Advisers's CTSO Position: Q4 2022 in Review

Two Sigma Advisers sold out of Cytosorbents Corp (CTSO) in Q4 2022, closing a stake of 830 shares — an estimated $23K sold.

Two Sigma Advisers first reported a position in CTSO in Q2 2018 and held it in 18 quarters. The position peaked at $2.44M in Q2 2018. 52 funds tracked by Wall St. Rank hold CTSO as of Q4 2022.

Two Sigma Advisers reported no remaining Cytosorbents Corp position as of Q4 2022 after selling out during the quarter.
Two Sigma Advisers sold 830 Cytosorbents Corp shares in Q4 2022, an estimated $23K.
Two Sigma Advisers first reported a position in Cytosorbents Corp in Q2 2018 and held it in 18 quarters.
Two Sigma Advisers's Cytosorbents Corp position peaked at $2.44M in Q2 2018.
52 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.